In addition, Sal acts as an effective treatment option through the FGF2-mediated cAMP/PKA/CREB signaling pathway to reduce inflammation, apoptosis and promote dendritic and synaptic plasticity after ischemic stroke. This evidence concerns the gene FGF2 and ischemic stroke.